Cover Image

Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report

Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report

Saved in:
Bibliographic Details
Main Authors: Li, Bowen (Author) , Jia, Ziqi (Author) , Huang, Zhicheng (Author) , Xue, Jianchao (Author) , Wang, Yadong (Author) , Guo, Chao (Author) , Si, Xiaoyan (Author) , Chen, Zexin (Author) , Li, Ji (Author) , Chen, Rongrong (Author) , Bie, Zhixin (Author) , Giglio, Andrea De (Author) , Christopoulos, Petros (Author) , Liang, Naixin (Author) , Li, Shanqing (Author)
Format: Article (Journal)
Language:English
Published: November 30, 2023
In: Translational Lung Cancer Research
Year: 2023, Volume: 12, Issue: 11, Pages: 2322-2329
ISSN:2226-4477
DOI:10.21037/tlcr-23-487
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.21037/tlcr-23-487
Verlag, kostenfrei, Volltext: https://tlcr.amegroups.org/article/view/80018
Get full text
Author Notes:Bowen Li, Ziqi Jia, Zhicheng Huang, Jianchao Xue, Yadong Wang, Chao Guo, Xiaoyan Si, Zexin Chen, Ji Li, Rongrong Chen, Zhixin Bie, Andrea De Giglio, Petros Christopoulos, Naixin Liang, Shanqing Li
Description
Summary:Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report
Item Description:Gesehen am 08.12.2023
Physical Description:Online Resource
ISSN:2226-4477
DOI:10.21037/tlcr-23-487

Similar Items